DBVT
DBV Technologies S.A.
There isn't enough reported data to score DBVT yet.
DBVT Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Weak | |
| Unavailable |
DBVT's revenue, profitability and cash flow are currently weak. There isn't enough data to rate its balance sheet.
DBVT PE Valuation
DBVT has no meaningful PE right now: it lost money over the past year.
DBVT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Moderate |
Analysts expect DBVT's losses to shrink, with revenue growing.
DBVT Earnings Per Share
DBVT is still losing money, but far less than before: $0.61 per share over the past year, against $13.30 at its worst in mid-2022.
DBVT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.6M | -42% |
| Q2 2026 | $700K | -52% |
| Q1 2026 | $900K | +20% |
| Q4 2025 | $645K | +26% |
| Q3 2025 | $2.8M | +159% |
| Q2 2025 | $1.5M | +26% |
| Q1 2025 | $753K | -46% |
| Q4 2024 | $511K | -94% |
DBVT's revenue has slid since its 2023 peak: $2M last quarter, down 42% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -4050% | -2814 points |
| Q2 2026 | -7229% | -4422 points |
| Q1 2026 | -5322% | -1787 points |
| Q4 2025 | -6985% | -2315 points |
| Q3 2025 | -1236% | +1593 points |
| Q2 2025 | -2806% | +109 points |
| Q1 2025 | -3535% | -1505 points |
| Q4 2024 | -4669% | -4535 points |
DBVT's operating margin was −4050% last quarter, down 2814 points from the same quarter a year ago.
DBVT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$53.7M | -$21.1M |
| Q2 2026 | -$53M | -$19.1M |
| Q1 2026 | -$49.5M | -$29.8M |
| Q4 2025 | -$35.5M | -$23.4M |
| Q3 2025 | -$32.6M | -$9.7M |
| Q2 2025 | -$33.9M | +$1.9M |
| Q1 2025 | -$19.7M | +$16.3M |
| Q4 2024 | -$12.1M | +$1.9M |
DBVT has burned cash in almost every quarter: −$192M over the past year, against −$98M the year before.
DBVT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4% | +17.5M shares |
| 1 year | +235% | +317M shares |
| 3 years | +4700% | +442M shares |
DBVT has 451M diluted shares, up 235% from a year ago.
DBVT Net Leverage
DBVT's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
DBVT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.9 | Neutral |
| Stochastic | 28.1 | Neutral |
DBVT's weekly RSI is 42 (neutral) and its Stochastic is 28 (neutral).
DBVT PE vs Healthcare Sector
DBVT has no meaningful PE right now: it lost money over the past year.
DBVT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.3 | 11% above |
| 20 week MA | $12.5 | 8.3% below |
| 50 week MA | $16.8 | 32% below |
| 100 week MA | $12.7 | 10% below |
| 200 week MA | $13.0 | 12% below |
DBVT has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 12% below its 200-week average.
DBVT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $37.4 | $25.8 | -31% |
| 2021 | $25.8 | $16.9 | -34% |
| 2022 | $16.9 | $14.4 | -15% |
| 2023 | $14.4 | $9.55 | -34% |
| 2024 | $9.55 | $3.19 | -67% |
| 2025 | $3.19 | $19.2 | +501% |
| 2026 YTD | $19.2 | $11.4 | -40% |
DBVT's yearly returns have swung widely, from +501% in 2025 to −67% in 2024. It's down 40% so far in 2026.